Narcan and Keppra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Narcan (naloxone hydrochloride) and Keppra (levetiracetam). Common drug interactions include encephalopathy among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Narcan and Keppra. It is created by eHealthMe based on reports of 68 people who take the same drugs from the FDA, and is updated regularly.

What is Narcan?

Narcan has active ingredients of naloxone hydrochloride. eHealthMe is studying from 3,687 Narcan users. Check the latest studies of Narcan.

What is Keppra?

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Sep, 04, 2026

68 people who take Narcan and Keppra together, and have interactions are studied.

Narcan and Keppra drug interactions.

What are the common drug interactions of Narcan and Keppra, by gender? *:

female:

  1. Encephalopathy (functioning of the brain is affected by some agent or condition)
  2. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  3. Nausea (feeling of having an urge to vomit)
  4. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  5. Surgical failure
  6. Tremor (trembling or shaking movements in one or more parts of your body)
  7. Vision blurred
  8. Visual impairment
  9. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  10. Contusion (a type of hematoma of tissue in which capillaries)

male:

  1. Arthralgia (joint pain)
  2. Rash
  3. Pigmentation disorder (disturbances of human skin colour)
  4. Purpura (purplish discoloration of the skin)
  5. Rash macular (small, flat red spots)
  6. Skin hyperpigmentation (disorders affect the colour of your skin)
  7. Skin plaque (red, scaly patches to appear on the skin)
  8. Skin ulcer haemorrhage (bleeding skin ulcer)
  9. Mobility decreased (ability to move is reduced)
  10. Pain in extremity

What are the common drug interactions of Narcan and Keppra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Tachycardia (a heart rate that exceeds the range of 100 beats/min)
  2. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  3. Blood creatinine increased
  4. Blood lactic acid increased
  5. Blood urea increased
  6. Bone marrow failure
  7. Bradycardia (abnormally slow heart action)
  8. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  9. Cytokine storm (over-protective immune response that can actually be fatal)
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

20-29:

  1. Proctalgia (pain in the rectum)
  2. Anaemia (lack of blood)
  3. Anaphylactoid reaction (type of anaphylaxis that does not involve an allergic reaction but is due to direct mast cell degranulation)
  4. B-cell type acute leukaemia (cancer of the white blood cells)
  5. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  6. Candida sepsis (candida in blood stream)
  7. Clostridium difficile colitis (inflammation of colon by clostridium difficile bacteria infection)
  8. Confusional state
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)

30-39:

  1. Arthralgia (joint pain)
  2. Ecchymosis (a discoloration of the skin resulting from bleeding underneath)
  3. Generalised oedema (swelling all over the body)
  4. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  5. Oedema peripheral (superficial swelling)
  6. Pain
  7. Petechiae (a small red or purple spot caused by bleeding into the skin)
  8. Pigmentation disorder (disturbances of human skin colour)
  9. Purpura (purplish discoloration of the skin)
  10. Rash

40-49:

  1. Fatigue (feeling of tiredness)
  2. Hypersomnia (excessive daytime sleepiness (eds))
  3. Arthralgia (joint pain)
  4. Asthenia (weakness)
  5. Back pain
  6. Catheter site discharge
  7. Cellulitis (infection under the skin)
  8. Confusional state
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)

50-59:

  1. Colitis (inflammation of colon)
  2. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Fall
  5. Hyperhidrosis (abnormally increased sweating)
  6. Hypoaesthesia (reduced sense of touch or sensation)
  7. Limb discomfort (discomfort in leg)
  8. Migraine (headache)
  9. Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  10. Nasopharyngitis (inflammation of the nasopharynx)

60+:

  1. Somnolence (a state of near-sleep, a strong desire for sleep)
  2. Encephalopathy (functioning of the brain is affected by some agent or condition)
  3. Thrombosis (formation of a blood clot inside a blood vessel)
  4. Wound infection
  5. Abdominal hernia
  6. Abdominal pain
  7. Actinomycosis (infection that causes sores, or abscesses)
  8. Activities of daily living impaired
  9. Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
  10. Adenocarcinoma (malignant tumour formed from glandular structures in epithelial tissue)

What are the existing conditions these people have? *

  1. Pain: 23 people, 33.82%
  2. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 13 people, 19.12%
  3. Depression: 10 people, 14.71%
  4. Nausea (feeling of having an urge to vomit): 10 people, 14.71%
  5. Stress And Anxiety: 9 people, 13.24%
  6. Nausea And Vomiting: 8 people, 11.76%
  7. Migraine (headache): 7 people, 10.29%
  8. Back Pain: 7 people, 10.29%
  9. Constipation: 7 people, 10.29%
  10. Nuclear Magnetic Resonance Imaging Brain: 7 people, 10.29%

* Approximation only. Some reports may have incomplete information.

Do you take Narcan and Keppra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Narcan and Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Narcan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Keppra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Narcan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keppra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on naloxone hydrochloride and levetiracetam (the active ingredients of Narcan and Keppra, respectively), and Narcan and Keppra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: